by McKesson Ventures | Jun 15, 2023 | Press Releases
McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are...
by McKesson Ventures | Jun 13, 2023 | Press Releases
Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon...
by McKesson Ventures | Jun 13, 2023 | Press Releases
McKesson Ventures portfolio company Xealth was selected as a winner in the 25th anniversary Digital Health Awards® program. This competition recognizes the best digital health resources. “Shaping Your Digital Health Future” received a Gold Award for Connected Digital...
by McKesson Ventures | Jun 6, 2023 | Media Coverage, Press Releases
McKesson Ventures has participated in a $17.5 million Series A round for RxLightning, a platform for streamlining access and affordability for specialty medications. This brings the total the company has raised since its inception to $20.5 million. With RxLightning,...
by McKesson Ventures | Jun 2, 2023 | Press Releases
Aster Insights, a provider of technology-enabled data and analytics solutions for oncology discovery, has announced that The University of Kansas Cancer Center will join its Oncology Research Information Exchange Network (ORIEN). The KU Cancer Center is the latest...
by McKesson Ventures | May 30, 2023 | Press Releases
Aster Insights has announced its participation as a research partner at the American Society of Clinical Oncology (ASCO) Annual Meeting June 2-6, 2023, in Chicago. An oral presentation and three posters will be presented at this year’s ASCO meeting, utilizing the...
